Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Increasing tolerance of hospital Enterococcus faecium to handwash alcohols.

Pidot SJ, Gao W, Buultjens AH, Monk IR, Guerillot R, Carter GP, Lee JYH, Lam MMC, Grayson ML, Ballard SA, Mahony AA, Grabsch EA, Kotsanas D, Korman TM, Coombs GW, Robinson JO, Gonçalves da Silva A, Seemann T, Howden BP, Johnson PDR, Stinear TP.

Sci Transl Med. 2018 Aug 1;10(452). pii: eaar6115. doi: 10.1126/scitranslmed.aar6115.

PMID:
30068573
2.

Optimising early identification of blood culture isolates by MALDI-TOF and use of multiple target wells.

Fang YT, Grabsch EA, Leroi MJ, Sherry NL, Ward PB.

Pathology. 2018 Aug;50(5):584-587. doi: 10.1016/j.pathol.2017.12.346. No abstract available.

PMID:
30031561
3.

Vancomycin-resistant Enterococcus faecium sequence type 796 - rapid international dissemination of a new epidemic clone.

Mahony AA, Buultjens AH, Ballard SA, Grabsch EA, Xie S, Seemann T, Stuart RL, Kotsanas D, Cheng A, Heffernan H, Roberts SA, Coombs GW, Bak N, Ferguson JK, Carter GC, Howden BP, Stinear TP, Johnson PDR.

Antimicrob Resist Infect Control. 2018 Mar 22;7:44. doi: 10.1186/s13756-018-0335-z. eCollection 2018.

4.

Superbugs in the supermarket? Assessing the rate of contamination with third-generation cephalosporin-resistant gram-negative bacteria in fresh Australian pork and chicken.

McLellan JE, Pitcher JI, Ballard SA, Grabsch EA, Bell JM, Barton M, Grayson ML.

Antimicrob Resist Infect Control. 2018 Feb 23;7:30. doi: 10.1186/s13756-018-0322-4. eCollection 2018.

5.

Evolutionary origins of the emergent ST796 clone of vancomycin resistant Enterococcus faecium.

Buultjens AH, Lam MM, Ballard S, Monk IR, Mahony AA, Grabsch EA, Grayson ML, Pang S, Coombs GW, Robinson JO, Seemann T, Johnson PD, Howden BP, Stinear TP.

PeerJ. 2017 Jan 24;5:e2916. doi: 10.7717/peerj.2916. eCollection 2017.

6.

Assessment of the BD GeneOhm MRSA ACP assay using combined swabs for the detection of methicillin resistant Staphylococcus aureus (MRSA) colonisation.

Grabsch EA, Xie S, Szczurek PB, Grayson ML, Howden BP.

Pathology. 2013 Oct;45(6):612-4. doi: 10.1097/PAT.0b013e3283653b48. No abstract available.

PMID:
24018809
7.

Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme.

Grabsch EA, Mahony AA, Cameron DR, Martin RD, Heland M, Davey P, Petty M, Xie S, Grayson ML.

J Hosp Infect. 2012 Dec;82(4):234-42. doi: 10.1016/j.jhin.2012.08.010. Epub 2012 Oct 25.

PMID:
23103245
8.

High-resolution melting genotyping of Enterococcus faecium based on multilocus sequence typing derived single nucleotide polymorphisms.

Tong SY, Xie S, Richardson LJ, Ballard SA, Dakh F, Grabsch EA, Grayson ML, Howden BP, Johnson PD, Giffard PM.

PLoS One. 2011;6(12):e29189. doi: 10.1371/journal.pone.0029189. Epub 2011 Dec 16.

9.

Quantitative efficacy of alcohol-based handrub against vancomycin-resistant enterococci on the hands of human volunteers.

Grayson ML, Ballard SA, Gao W, Khumra S, Ward P, Johnson PD, Grabsch EA.

Infect Control Hosp Epidemiol. 2012 Jan;33(1):98-100. doi: 10.1086/663342. Epub 2011 Nov 22. No abstract available.

PMID:
22173533
10.

Evaluation of the Xpertâ„¢ MRSA/SA Blood Culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens.

Kelley PG, Grabsch EA, Farrell J, Xie S, Montgomery J, Mayall B, Howden BP.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):404-7. doi: 10.1016/j.diagmicrobio.2011.02.006. Epub 2011 Apr 15.

PMID:
21497042
11.

A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.

Johnson PD, Ballard SA, Grabsch EA, Stinear TP, Seemann T, Young HL, Grayson ML, Howden BP.

J Infect Dis. 2010 Oct 15;202(8):1278-86. doi: 10.1086/656319.

PMID:
20812846
12.

Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control.

Dendle C, Martin RD, Cameron DR, Grabsch EA, Mayall BC, Grayson ML, Johnson PD.

Med J Aust. 2009 Oct 5;191(7):389-92.

PMID:
19807631
13.

Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSA.

Kelley PG, Grabsch EA, Howden BP, Gao W, Grayson ML.

J Clin Microbiol. 2009 Nov;47(11):3769-72. doi: 10.1128/JCM.00303-09. Epub 2009 Aug 26.

14.

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.

Horne KC, Howden BP, Grabsch EA, Graham M, Ward PB, Xie S, Mayall BC, Johnson PD, Grayson ML.

Antimicrob Agents Chemother. 2009 Aug;53(8):3447-52. doi: 10.1128/AAC.01365-08. Epub 2009 Jun 8.

15.

Outbreak of vancomycin-resistant Enterococcus faecium containing both vanA and vanB gene clusters.

Dendle C, Ballard SA, Grabsch EA, Gao W, Grayson ML.

J Hosp Infect. 2009 Apr;71(4):379-81. doi: 10.1016/j.jhin.2008.12.006. Epub 2009 Feb 5. No abstract available.

PMID:
19200618
16.
17.

Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation.

Grabsch EA, Chua K, Xie S, Byrne J, Ballard SA, Ward PB, Grayson ML.

J Clin Microbiol. 2008 Jun;46(6):1961-4. doi: 10.1128/JCM.01778-07. Epub 2008 Apr 23.

18.

High rates of fecal carriage of nonenterococcal vanB in both children and adults.

Graham M, Ballard SA, Grabsch EA, Johnson PD, Grayson ML.

Antimicrob Agents Chemother. 2008 Mar;52(3):1195-7. doi: 10.1128/AAC.00531-07. Epub 2008 Jan 7.

19.
21.

Risk of environmental and healthcare worker contamination with vancomycin-resistant enterococci during outpatient procedures and hemodialysis.

Grabsch EA, Burrell LJ, Padiglione A, O'Keeffe JM, Ballard S, Grayson ML.

Infect Control Hosp Epidemiol. 2006 Mar;27(3):287-93. Epub 2006 Feb 28.

PMID:
16532417
22.

Community and health-care associated non-multiresistant methicillin-resistant Staphylococcus aureus in Victoria.

Howden BP, Grabsch EA, King H, Graham M, Johnson PD, Korman TM, Grayson ML, Mayall BC.

Med J Aust. 2005 Nov 21;183(10):548. No abstract available.

PMID:
16296982
23.

Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection.

Johnson PD, Martin R, Burrell LJ, Grabsch EA, Kirsa SW, O'Keeffe J, Mayall BC, Edmonds D, Barr W, Bolger C, Naidoo H, Grayson ML.

Med J Aust. 2005 Nov 21;183(10):509-14.

PMID:
16296963
24.

Prevalence of colonisation with vancomycin-resistant enterococci (VRE) among haemodialysis outpatients in Victoria: implications for screening.

Burrell LJ, Grabsch EA, Padiglione AA, Grayson ML.

Med J Aust. 2005 May 2;182(9):492. No abstract available.

PMID:
15865598
26.

In-use efficacy of a chlorhexidine in alcohol surgical rub: a comparative study.

Grabsch EA, Mitchell DJ, Hooper J, Turnidge JD.

ANZ J Surg. 2004 Sep;74(9):769-72.

PMID:
15379808
27.

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.

Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PD, Morris AJ, Mayall BC, Grayson ML.

Clin Infect Dis. 2004 Feb 15;38(4):521-8. Epub 2004 Jan 29.

PMID:
14765345
28.

Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.

Padiglione AA, Wolfe R, Grabsch EA, Olden D, Pearson S, Franklin C, Spelman D, Mayall B, Johnson PD, Grayson ML.

Antimicrob Agents Chemother. 2003 Aug;47(8):2492-8.

29.

Bactericidal efficacy of sterilizing protocol for reused cardiac electrophysiology catheters.

Grabsch EA, Grayson ML, Johnson PD, Yates LA, Harper RW, Smolich JJ.

Am J Cardiol. 2002 Mar 15;89(6):770-2. No abstract available.

PMID:
11897224
30.

Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin.

Ward PB, Johnson PD, Grabsch EA, Mayall BC, Grayson ML.

Med J Aust. 2001 Nov 5;175(9):480-3.

PMID:
11758077
31.

Fecal colonization with vancomycin-resistant enterococci in Australia.

Padiglione AA, Grabsch EA, Olden D, Hellard M, Sinclair MI, Fairley CK, Grayson ML.

Emerg Infect Dis. 2000 Sep-Oct;6(5):534-6.

32.

Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria.

Grayson ML, Grabsch EA, Johnson PD, Olden D, Aberline M, Li HY, Hogg G, Abbott M, Kerr PG.

Med J Aust. 1999 Aug 2;171(3):133-6.

PMID:
10474604
33.

Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.

McNeil JJ, Grabsch EA, McDonald MM.

Med J Aust. 1999 Mar 15;170(6):270-3. Review.

PMID:
10212650

Supplemental Content

Loading ...
Support Center